Rockwell Medical Analyst Ratings
Rockwell Medical Analyst Ratings
罗克韦尔医疗分析师评级
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/28/2023 | 494.59% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
08/15/2023 | 494.59% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
07/17/2023 | 494.59% | HC Wainwright & Co. | $9 → $11 | Maintains | Buy |
05/30/2023 | 386.49% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
05/02/2023 | 278.38% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
04/04/2023 | 278.38% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
02/13/2023 | 278.38% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
02/08/2023 | 278.38% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
08/30/2022 | 332.43% | HC Wainwright & Co. | $3 → $8 | Maintains | Buy |
01/18/2022 | 62.16% | HC Wainwright & Co. | $5 → $3 | Maintains | Buy |
09/07/2021 | 170.27% | HC Wainwright & Co. | $5.5 → $5 | Maintains | Buy |
02/08/2021 | 197.3% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
04/07/2020 | 386.49% | HC Wainwright & Co. | $11 → $9 | Maintains | Buy |
11/12/2019 | 224.32% | Piper Sandler | $10 → $6 | Maintains | Overweight |
06/25/2019 | 494.59% | Cantor Fitzgerald | → $11 | Initiates Coverage On | → Overweight |
06/24/2019 | 440.54% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
10/19/2018 | 494.59% | IFS Securities | → $11 | Downgrades | Strong Buy → Outperform |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
09/28/2023 | 494.59% | HC Wainwright公司 | →$11 | 重申 | 购买→购买 |
2023年08月15日 | 494.59% | HC Wainwright公司 | →$11 | 重申 | 购买→购买 |
07/17/2023 | 494.59% | HC Wainwright公司 | $9→$11 | 维护 | 买 |
2023年05月30日 | 386.49% | HC Wainwright公司 | $7→$9 | 维护 | 买 |
05/02/2023 | 278.38% | HC Wainwright公司 | →$7 | 重申 | →购买 |
04/04/2023 | 278.38% | HC Wainwright公司 | →$7 | 重申 | →购买 |
02/13/2023 | 278.38% | HC Wainwright公司 | →$7 | 重申 | →购买 |
02/08/2023 | 278.38% | HC Wainwright公司 | $8→$7 | 维护 | 买 |
2022年08月30日 | 332.43% | HC Wainwright公司 | $3→$8 | 维护 | 买 |
01/18/2022 | 62.16% | HC Wainwright公司 | $5→$3 | 维护 | 买 |
09/07/2021 | 170.27% | HC Wainwright公司 | $5.5→$5 | 维护 | 买 |
02/08/2021 | 197.3% | HC Wainwright公司 | $9→$5.5 | 维护 | 买 |
04/07/2020 | 386.49% | HC Wainwright公司 | $11→$9 | 维护 | 买 |
2019年11月12日 | 224.32% | 派珀·桑德勒 | $10→$6 | 维护 | 超重 |
2019年06月25日 | 494.59% | 康托·菲茨杰拉德 | →$11 | 开始承保 | →超重 |
2019年06月24日 | 440.54% | 派珀·桑德勒 | →$10 | 开始承保 | →超重 |
2018年10月19日 | 494.59% | IFS证券 | →$11 | 评级下调 | 强势买入→跑赢大盘 |
What is the target price for Rockwell Medical (RMTI)?
罗克韦尔医疗公司(RMTI)的目标价格是多少?
There is no price target for Rockwell Medical
罗克韦尔医疗公司没有价格目标
What is the most recent analyst rating for Rockwell Medical (RMTI)?
罗克韦尔医疗公司(RMTI)最近的分析师评级是多少?
There is no analyst for Rockwell Medical
罗克韦尔医疗公司没有分析师
When is the next analyst rating going to be posted or updated for Rockwell Medical (RMTI)?
罗克韦尔医疗公司(RMTI)的下一次分析师评级将于何时发布或更新?
There is no next analyst rating for Rockwell Medical
罗克韦尔医疗公司没有下一个分析师评级
Is the Analyst Rating Rockwell Medical (RMTI) correct?
分析师对罗克韦尔医疗公司(RMTI)的评级正确吗?
There is no next analyst rating for Rockwell Medical
罗克韦尔医疗公司没有下一个分析师评级